Skip Navigation
Search Menu
Find a Doctor


Photo of Dr. Michael Xing

Michael Mingzhao Xing, M.D., Ph.D.

Professor of Medicine

Male  | Languages: English, Chinese

Appointment Phone


Main Location

Johns Hopkins Outpatient Center

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »


  • Professor of Medicine
  • Professor of Oncology
  • Professor of Pathology

Centers & Institutes



Johns Hopkins Outpatient Center

Appointment Phone: 410-955-9270

601 N. Caroline Street
Baltimore, MD 21287 map
Phone: 410-502-6888
Fax: 410-367-2042

The Johns Hopkins Hospital

Appointment Phone: 410-955-9270

600 N. Wolfe Street
Sheikh Zayed Tower Suite 333
Baltimore, MD 21287 map
Phone: 410-502-6888
Fax: 410-367-2042


Endocrine Diseases, Endocrinology, Hyperthyroidism, Hypothyroidism, Thyroid Cancer, Thyroid Disorders, Thyroid Nodules

Research Interests

Thyroid Cancer and Thyroid Nodules

    Additional Information

  • Education +


    • Second Military Medical University / MD (1984)


    • Greater Baltimore Medical Center / Internal Medicine (2000)


    • University of California San Diego School of Medicine / Pharmacology (1997)
    • Johns Hopkins University School of Medicine / Endocrinology and Metabolism (2003)


    • American Board of Internal Medicine / Endocrinology/Diabetes/Metabolism (2003)
    • American Board of Internal Medicine / Internal Medicine (2000)
  • Research & Publications +

    Clinical Trial Keywords: Thyroid Cancer, novel therapeutic agents, diagnostic and prognostic molecular markers

    Selected Publications

    Hu, S.; Ewertz, M.; Tufano, R.P.; Brait, M.; Carvalho, A.L.; Liu, D.; Tufaro, A.P.; Basaria, S.; Cooper, D.S.; Sidransky, D.; Ladenson, P.W.; Xing, M. Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer. J Clin Endocrinol Metab. 2006 Jan;91(1):98-104.

    Hu, S.; Liu, D.; Tufano, R.P.; Carson, K.A.; Rosenbaum, E.; Cohen, Y.; Holt, E.H.; Kiseljak-Vassiliades, K.; Rhoden, K.J.; Tolaney, S.; Condouris, S.; Tallini, G.; Westra, W.H.; Umbricht, C.B.; Zeiger, M.A.; Califano, J.A.; Vasko, V.; Xing, M. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer. 2006 Nov 15;119(10):2322-2329.

    Ball, D.W.; Jin, N.; Rosen, D.M.; Dackiw, A.; Sidransky, D.; Xing, M.; Nelkin, B.D. Selective Growth Inhibition in BRAF Mutant Thyroid Cancer by the Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244. J Clin Endocrinol Metab. 2007 Dec;92(12):4712-4718.
  • Academic Affiliations & Courses +
  • Activities & Honors +
  • Videos & Media +
Is This You? Edit Profile